HR 8816
American Medical Innovation and Investment Act of 2024
Official facts
These fields are copied from the synchronized official record.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
Lifecycle
This section is generated by FederalStateData from accepted bill actions and remains labeled as derived.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
Sponsors and cosponsors
| Member | Party | Role | Sources |
|---|---|---|---|
| Vern Buchanan | Republican Party | PRIMARY |
Actions
Dec 27, 2024 · Committee
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
Jun 27, 2024 · Committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 40 - 0.
Jun 27, 2024 · Committee
Committee Consideration and Mark-up Session Held
Jun 25, 2024 · IntroReferral
Introduced in House
Jun 25, 2024 · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Amendments
Committees
| Committee | Chamber | Relationship | Source |
|---|---|---|---|
| Energy and Commerce Committeehsif00 | HOUSE | REFERRED | Official relationship ↗ |
| Ways and Means Committeehswm00 | HOUSE | REFERRED | Official relationship ↗ |